BioLingus (Cayman) Limited

January 26, 2024

VIA EDGAR

Tyler Howes/ Jason Drory

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Manufacturing

100 F Street, NE

Washington, D.C., 20549

Re:	BioLingus (Cayman) Limited
	Registration Statement on Form F-1, as amended (File No. 333-273093)
	Request for Acceleration of Effectiveness

Ladies and Gentlemen:

In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, BioLingus (Cayman) Limited hereby requests acceleration of the effectiveness of the above-referenced Registration Statement on Form F-1, as amended, so that such Registration Statement will become effective at 5:00 p.m., Eastern Time, on January 31, 2024, or as soon thereafter as practicable.

The Company understands that the Commission will consider this request for acceleration of the effective date of the Registration Statement as a confirmation of the fact that the Company is aware of its responsibilities under the Securities Act as they relate to the proposed public offering of the securities specified in the Registration Statement.

Very truly yours,
BioLingus (Cayman) Limited
By:	/s/ Yves Decadt
Name:	Yves Decadt
Title:	Chief Executive Officer